ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ADIL Adial Pharmaceuticals Inc

2.31
-0.30 (-11.49%)
After Hours
Last Updated: 16:05:49
Delayed by 15 minutes

Period:

Draw Mode:

Volume 660,875
Bid Price 2.31
Ask Price 2.35
News -
Day High 2.62

Low
0.765

52 Week Range

High
14.00

Day Low 2.2289
Share Name Share Symbol Market Stock Type
Adial Pharmaceuticals Inc ADIL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.30 -11.49% 2.31 16:05:49
Open Price Low Price High Price Close Price Previous Close
2.60 2.2289 2.62 2.24 2.61
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,884 660,875 US$ 2.40 US$ 1,584,805 - 0.765 - 14.00
Last Trade Type Quantity Price Currency
16:00:26 formt 7,593 US$ 2.31 USD

Adial Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.73M 1.22M - 0 -12.73M -10.45 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Adial Pharmaceuticals News

Date Time Source News Article
4/10/202407:30GlobeNewswire Inc.Adial Pharmaceuticals Announces Peer-Reviewed Publication..
4/02/202407:30GlobeNewswire Inc.Adial Pharmaceuticals Reports 2023 Fiscal Year Financial..
3/01/202418:00GlobeNewswire Inc.Adial Pharmaceuticals Announces Exercise of Warrants for..
2/28/202408:30GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent from the United..
2/14/202414:22Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
2/13/202408:15GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent Notice of Allowance..
1/25/202415:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
1/24/202423:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
1/18/202415:15Edgar (US Regulatory)Form 8-K - Current report
1/18/202407:30GlobeNewswire Inc.Adial Announces Appointment of Tony Goodman as Chief..
1/16/202415:17Edgar (US Regulatory)Form 8-K - Current report
1/12/202415:51Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ADIL Message Board. Create One! See More Posts on ADIL Message Board See More Message Board Posts

Historical ADIL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.143.101.09782.5029,960,3071.17102.63%
1 Month1.603.101.052.468,145,5780.7144.38%
3 Months1.344.120.7652.306,851,4270.9772.39%
6 Months2.784.120.7652.303,230,379-0.47-16.91%
1 Year7.12514.000.7654.242,256,197-4.82-67.58%
3 Years55.75127.000.76517.181,064,720-53.44-95.86%
5 Years74.25127.000.76528.16872,240-71.94-96.89%

Adial Pharmaceuticals Description

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

Your Recent History

Delayed Upgrade Clock